IDO1: Indoleamine 2,3-Dioxygenase 1

A key immunomodulatory enzyme in tryptophan catabolism and immune tolerance

Gene Information Card

Symbol IDO1
Full Name Indoleamine 2,3-Dioxygenase 1
Gene Type Protein coding
Chromosomal Location 8p11.21
NCBI Gene ID 3620 ncbi.nlm.nih.gov/gene/3620
Ensembl ID ENSG00000131203
UniProt ID P14902
OMIM ID 147435
HGNC ID 5389
Aliases IDO, INDO, IDO-1

Description

IDO1 encodes indoleamine 2,3-dioxygenase 1, a heme-containing enzyme that catalyzes the first and rate-limiting step in the kynurenine pathway of tryptophan catabolism. It converts L-tryptophan to N-formylkynurenine. IDO1 is expressed in various tissues and cell types, particularly in antigen-presenting cells, and plays a critical role in immune regulation by depleting tryptophan and producing immunomodulatory metabolites. Overexpression is associated with immune tolerance in cancer and chronic infections.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various) IDO1 overexpression depletes tryptophan and generates kynurenines, suppressing T-cell responses and promoting immune evasion. PMID: 22992522; ClinVar
Alzheimer's disease Increased IDO1 activity leads to neurotoxic kynurenine metabolites and neuroinflammation. PMID: 25655837
Rheumatoid arthritis IDO1 upregulation in synovial tissue contributes to local immune suppression and chronic inflammation. PMID: 16920931
HIV infection IDO1 activation in dendritic cells induces tryptophan depletion and T-cell dysfunction. PMID: 15265943

Expression Profile

Tissue Expression
Tissue nTPM level
Placenta 12.5 High
Lung 8.2 Medium
Small intestine 6.7 Medium
Spleen 5.1 Medium
Liver 2.3 Low
Brain 1.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.3 Cervical cancer cell line; high IDO1 expression
A549 9.8 Lung adenocarcinoma cell line
THP-1 7.4 Monocytic leukemia cell line; inducible by IFN-γ
MCF7 2.1 Breast cancer cell line; low basal expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.359C>T (p.Ser120Leu) Missense <0.01% Reduced enzyme activity; reported in ClinVar
c.766G>A (p.Gly256Arg) Missense <0.01% Unknown functional effect
c.1129G>A (p.Gly377Ser) Missense <0.01% Reported in COSMIC; potential loss of function
Mutation functional classification

Loss of Function (LOF)

Mutations such as p.Ser120Leu reduce catalytic activity, impairing tryptophan degradation and immune modulation.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in IDO1.

Dominant Negative (DN)

No dominant-negative mutations described for IDO1.

Gene Ontology (GO)

tryptophan 2 (GO:0004833) cytoplasm (GO:0005737)
cytosol (GO:0005829) • L-tryptophan catabolic process to kynurenine (GO:0019447)
negative regulation of T cell proliferation (GO:0042130) T cell homeostasis (GO:0043029)

Pathways

KEGG: Tryptophan metabolism (hsa00380)
KEGG: Kynurenine pathway
Reactome: Tryptophan catabolism (R-HSA-71240)
Reactome: IDO1-mediated immune regulation

Protein Summary

IDO1 is a 403-amino-acid heme-containing enzyme that catalyzes the oxidative cleavage of the indole ring of L-tryptophan to form N-formylkynurenine. It is a key regulator of immune responses through tryptophan depletion and production of kynurenine metabolites that suppress T-cell activity and promote regulatory T-cell differentiation. IDO1 is induced by inflammatory stimuli such as interferon-gamma and is a target for cancer immunotherapy.

Related Products

Product name Cat.No. Species Gene ID
IDO1 Knockout HEK293 Cell Line EDJ-KQ1085 Human 3620 Details Get a Quote
IDO1 Knockout HeLa Cell Line EDJ-KQ53658 Human 3620 Details Get a Quote
IDO1 Knockout A-549 Cell Line EDJ-KQ62132 Human 3620 Details Get a Quote
IDO1 Knockout HCT 116 Cell Line EDJ-KQ70622 Human 3620 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: